Item 9 Labs Corp.
INLB
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Net Income | -31.03M | -30.59M | -31.06M | -31.14M | -21.74M |
| Total Depreciation and Amortization | 1.83M | 1.90M | 1.92M | 1.92M | 2.27M |
| Total Amortization of Deferred Charges | 3.00M | 3.08M | 3.32M | 3.81M | 5.64M |
| Total Other Non-Cash Items | 14.30M | 14.30M | 14.93M | 15.30M | 4.60M |
| Change in Net Operating Assets | 10.79M | 7.65M | 7.56M | 7.86M | 8.10M |
| Cash from Operations | -1.12M | -3.66M | -3.32M | -2.25M | -1.13M |
| Capital Expenditure | -1.48M | -1.10M | -1.84M | -4.33M | -2.90M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -3.30K | -73.30K | -137.90K | -137.90K | -224.60K |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 21.50K | 17.90K | -1.75M | -695.10K | -713.80K |
| Cash from Investing | -1.46M | -1.15M | -3.73M | -5.16M | -3.84M |
| Total Debt Issued | 3.97M | 7.02M | 9.51M | 9.42M | 8.51M |
| Total Debt Repaid | -1.63M | -2.49M | -3.16M | -3.90M | -3.87M |
| Issuance of Common Stock | 101.90K | 369.00K | 657.80K | 657.80K | 587.70K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -116.00K | -88.70K | -105.70K | -124.50K | -113.50K |
| Cash from Financing | 2.32M | 4.81M | 6.91M | 6.05M | 5.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -258.20K | -4.00K | -139.00K | -1.37M | 144.80K |